Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis: Property investors look to healthcare

The promise of a bottom in Singapore’s office market has caused its ranking as an investment market to soar from next-to-bottom last year to third in this year’s “Emerging Trends in Real Estate Asia Pacific 2018” report, a real estate forecast jointly published by the Urban Land Institute (ULI) and PwC.

After two years of declining rents caused by a sluggish economy and a glut of supply, investors believe Singapore’s commercial and residential markets is near its bottom. Office rents in Singapore have firmed probably earlier than expected, while completion of the region’s biggest office deal in September has galvanised the local market and set a floor for valuations.

Several core office transactions have taken place this year, with foreign funds buying actively. The residential sector is also showing signs of recovery, with rising transactions and a slight uptick in pricing for the first time in four years. Sales of developer sites have surged amid tightening supply as developers seek to replenish the land banks. The rebound seems likely to be sustainable, given several years of pent-up consumer demand. The Chinese developers have also been active in buying land, pushing up land auction prices for residential sites significantly through 2017.

“Singapore has shot up the office rankings this year and is now in third position,” said Khoo Teng Chye, chairman of ULI Singapore, and executive director, Centre for Liveable Cities. “This position is reassuring for Singapore’s investment prospects, given that we have major projects in the pipeline to transform our city, such as the development of Jurong Lake District as an exciting second Central Business District, and the doubling of capacities of both our air and sea ports.”

Of particular interest, there is increased investors’ interests in alternative asset classes such as healthcare care related assets and data centres,” said Yeow Chee Keong, real estate and hospitality leader, PwC Singapore. “We believe the way forward could be more collaboration between traditional real estate managers with healthcare service providers to enhance the yield on underutilised assets.”

Looking at the Asia Pacific region as a whole, of all the influences shaping investment flows into regional real estate, it is excess liquidity that is seen as having the biggest effect. Local sovereign and institutional funds bearing stockpiles of accumulated cash are buying property, both regionally and globally, creating competition for assets that is changing investment patterns in fundamental and often unexpected ways.

Changes include the realignment of traditional risk/return classifications, changing expectations over returns, the convergence of core and opportunistic investors on the value-add space, and investor migration into alternative asset classes and new markets that in the past were of little interest, including data centres, affordable housing projects, build-to-rent (or co-living) facilities and student and senior housing.

Other areas of interest include opportunities in co-working facilities, concerns about how the Asian retail sector will weather ecommerce challenges, and the ongoing exodus of money from Asian institutions into international markets.

This year’s investment prospect rankings reflect the growing divergence between investment strategies as buyers pursue either growth- or yield-driven approaches. Cities that are the biggest gainers in this year’s survey are those where investors seek to maximise returns via rental growth (Sydney and Melbourne), those that look for returns that are safe and low, but still higher than yields on sovereign bonds (Tokyo), or those that tap long-term secular growth in emerging markets (Vietnam). In addition, there was a change in investors’ sentiment toward Singapore, supported by the belief that there will be a recovery in both the office and residential sectors. In terms of prospects for individual property types, logistics assets take pole position this year, with investors showing renewed confidence in a story of long-term structural undersupply.

“The survey results show that Sydney and Melbourne appear at the top of this year’s rankings,” said Seek Ngee Huat, ULI Asia Pacific chairman and chairman, Global Logistic Properties. “Both cities combine the appeal of a stable investment environment with a combination of relatively good current yields and the prospect of strong rental growth going forward.”

“The unprecedented growth in capital outflows from Asian markets in 2017 almost double the outflow witnessed during the same period in 2016, with US$45.2 billion in outbound capital directed into global property assets,” said KK So, Asia Pacific real estate tax leader, PwC. “While the extent of the impact of the recent progressive tightening of Chinese capital controls remains unclear, the consensus is that overall outflows may not see a meaningful decline given firstly that sovereign and state investors will probably be unaffected and secondly that there is already a substantial body of Chinese-owned capital held outside mainland China, much of it in Hong Kong, that is not subject to the rules.”

Posted on: 23/11/2017 UTC+08:00


News

Cancer-detection company Grail has raised US$300 million Series C funding led by healthcare focused investment firm Ally Bridge Group, Hillhouse Capital and 6 Dimensions Capital.
ASX-listed, but New Zealand-based medical device manufacturer Adherium has appointed David Allinson as chief financial officer. This follows the sudden resignation of Timothy Marcotte at the end of January after only four months in the post.
Following Abano’s transition to focus solely on the NZ$11 billion (US$7.6 billion) trans-Tasman dental market, the NZX-listed specialist medical investment firm has appointed Tracey Batten to the board.
Rhythm Biosciences, which is developing a screening test intended for the accurate and early detection of colorectal cancer, has appointed Glenn Gilbert as chief operating officer. For the past eight years Gilbert has held various roles at the ASX listed pharmaceutical and device maker Medical Developments International, most recently as head of sales and marketing.
Peking University Founder Group continues to develop its bond curve with the sale of US$310 million new three-year floating rate notes at three-month Libor plus 400bp as well as a US$65 million tap of its 6.25% 2020 2.5-year fixed-rate bonds. They originally priced in mid April.
Matthew Ratty has stepped down from the board of Australian healthcare group Admedus after being appointed chief executive of performance-based online and mobile marketing solutions provider Tech Mpire.
Aoxin Q&M Dental Group (AQMD), a spin off of Singapore’s Q&M Dental Group, plans to acquire a dental hospital called Youxin Dental Clinic, better known as XY Dental, in Jinzhou City, Liaoning, for Rmb19.6 million (US$3.1 million).
Healthscope, Australia’s second largest private healthcare operator, has rejected two takeover bids saying that it will not provide due diligence access to either the BGH Capital/AustralianSuper consortium or Brookfield Asset Management. Instead, Healthscope said that it will undertake a strategic review of its hospital property portfolio.



Analysis

Sara Jost, global healthcare industry lead at BlackBerry, explains that putting the systems and procedures in place to deliver a healthy and secure digital healthcare system will protect patient health information and support medical innovation.
Joseph Soon, global digital director at Bupa, explains why industry players must stay agile in the market and act fast to take every opportunity the digital age has to offer.
The Asia-Pacific (APAC) healthcare industry is undergoing rapid transformation with a dramatic shift in consumer behaviour and expectations, opening up growth opportunities across diagnostics, regenerative medicine, medical tourism and digital health.
Tan Chorh Chuan, executive director at the Office for Healthcare Transformation and chief health scientist at the Ministry of Health in Singapore, explains why population health improvement has to become a crucial area of focus.
What an earth happened to Ping An Good Doctor? It was expected to be one of the brightest IPOs of the year and at HK$8.8 billion (US$1.1 billion) certainly one of the biggest out of Asia Pacific.
From aspirin to bone broths, the consumer healthcare market in Asia combines East and West and the growing population has more money to spend on healthy lifestyles. Sumit Sharma, head of health & life sciences, Asia Pacific, at Oliver Wyman, looks at how to identify new sources of value.
Fabian Boegershausen, manager at corporate strategy consulting firm Solidiance, takes a look at rising healthcare costs in ASEAN and provides measurable solutions to overcome future challenges.
Bain & Company’s seventh Global Healthcare Private Equity and Corporate M&A Report shows that Asia Pacific deals last year surged to their highest levels since 2001.
my images

Podcasts

HealthInvestor Asia twitter feed